Published: 27 November 2018
Author(s): Davide Rossi, Emanuele Zucca
Section: Editorial

Aging is a natural process leading to the progressive loss of physiological functions, increased inflammatory status, decreased naïve immune T-cell population, increased mutational events and epigenetic modifications resulting in an impaired health status. With the aging of the population, the number of older patients with hematologic disease will continue to increase. Since life expectancy for an 80 year-old patient can vary between 3 and 11 years according to his health status, it is of major importance to identify patients without irreversible comorbidities who have a significant life-expectancy and who would benefit most from the optimal treatment of the hematologic disease.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.